Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ossification, Heterotopic | 24 | 2020 | 240 | 6.300 |
Why?
|
Lymphatic Vessels | 4 | 2023 | 356 | 1.770 |
Why?
|
Lymphedema | 4 | 2023 | 526 | 1.620 |
Why?
|
Burns | 17 | 2020 | 1901 | 1.500 |
Why?
|
Wounds and Injuries | 12 | 2019 | 2517 | 1.300 |
Why?
|
Mammaplasty | 5 | 2019 | 1263 | 1.160 |
Why?
|
Mesenchymal Stem Cells | 13 | 2020 | 1672 | 1.150 |
Why?
|
Wound Healing | 13 | 2020 | 2815 | 1.060 |
Why?
|
Bone Morphogenetic Protein Receptors | 2 | 2017 | 47 | 1.050 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 3 | 2023 | 368 | 1.000 |
Why?
|
Osteogenesis | 12 | 2018 | 1295 | 1.000 |
Why?
|
Osteoblasts | 5 | 2019 | 1153 | 0.980 |
Why?
|
Mastectomy | 6 | 2022 | 1850 | 0.960 |
Why?
|
Breast Implantation | 2 | 2017 | 225 | 0.850 |
Why?
|
Breast Implants | 2 | 2017 | 414 | 0.790 |
Why?
|
Breast Neoplasms | 10 | 2023 | 21188 | 0.780 |
Why?
|
X-Ray Microtomography | 7 | 2016 | 457 | 0.780 |
Why?
|
Neovascularization, Physiologic | 3 | 2019 | 1371 | 0.770 |
Why?
|
Muscles | 2 | 2016 | 1582 | 0.760 |
Why?
|
Activin Receptors, Type I | 6 | 2017 | 134 | 0.760 |
Why?
|
Chondrogenesis | 4 | 2016 | 239 | 0.710 |
Why?
|
Anti-Obesity Agents | 1 | 2024 | 240 | 0.700 |
Why?
|
Lymph Node Excision | 5 | 2023 | 1273 | 0.600 |
Why?
|
Cartilage | 3 | 2016 | 811 | 0.600 |
Why?
|
Bone Morphogenetic Proteins | 4 | 2016 | 847 | 0.570 |
Why?
|
Spectrum Analysis, Raman | 2 | 2016 | 253 | 0.570 |
Why?
|
Burns, Electric | 1 | 2016 | 40 | 0.530 |
Why?
|
Cicatrix, Hypertrophic | 1 | 2017 | 80 | 0.530 |
Why?
|
Bone and Bones | 3 | 2016 | 2590 | 0.520 |
Why?
|
Myositis Ossificans | 1 | 2016 | 77 | 0.510 |
Why?
|
Skin Transplantation | 3 | 2017 | 1097 | 0.500 |
Why?
|
Arm Injuries | 1 | 2017 | 156 | 0.500 |
Why?
|
Tendons | 2 | 2016 | 557 | 0.490 |
Why?
|
Tenotomy | 6 | 2016 | 53 | 0.480 |
Why?
|
Achilles Tendon | 6 | 2016 | 181 | 0.480 |
Why?
|
Endothelial Cells | 2 | 2019 | 3592 | 0.480 |
Why?
|
Gene Targeting | 2 | 2017 | 841 | 0.470 |
Why?
|
Stress, Mechanical | 1 | 2019 | 1680 | 0.460 |
Why?
|
Bariatric Surgery | 1 | 2024 | 1001 | 0.450 |
Why?
|
Mastectomy, Subcutaneous | 1 | 2014 | 56 | 0.440 |
Why?
|
Abdomen | 2 | 2016 | 1137 | 0.430 |
Why?
|
Median Neuropathy | 1 | 2012 | 8 | 0.420 |
Why?
|
Stem Cell Transplantation | 3 | 2016 | 1602 | 0.420 |
Why?
|
Disease Models, Animal | 16 | 2020 | 18354 | 0.410 |
Why?
|
Cicatrix | 1 | 2019 | 799 | 0.410 |
Why?
|
Nipples | 1 | 2014 | 229 | 0.410 |
Why?
|
Free Tissue Flaps | 1 | 2016 | 337 | 0.390 |
Why?
|
Device Removal | 1 | 2017 | 643 | 0.390 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 627 | 0.390 |
Why?
|
Incidental Findings | 1 | 2016 | 697 | 0.380 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2016 | 755 | 0.380 |
Why?
|
Mice, Inbred C57BL | 19 | 2023 | 22379 | 0.370 |
Why?
|
SOX9 Transcription Factor | 3 | 2016 | 146 | 0.370 |
Why?
|
Blood Vessels | 1 | 2016 | 1110 | 0.360 |
Why?
|
Hamartoma | 1 | 2012 | 236 | 0.350 |
Why?
|
Integrases | 4 | 2019 | 520 | 0.350 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 1143 | 0.350 |
Why?
|
Weight Loss | 2 | 2024 | 2721 | 0.350 |
Why?
|
Mice | 28 | 2024 | 82072 | 0.340 |
Why?
|
Neutrophils | 2 | 2019 | 3785 | 0.330 |
Why?
|
Animals | 37 | 2024 | 169335 | 0.330 |
Why?
|
Axilla | 2 | 2023 | 625 | 0.320 |
Why?
|
Signal Transduction | 10 | 2019 | 23653 | 0.310 |
Why?
|
Lymphangiogenesis | 2 | 2022 | 171 | 0.310 |
Why?
|
Gastric Bypass | 1 | 2017 | 824 | 0.310 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 2063 | 0.290 |
Why?
|
Cell Lineage | 1 | 2016 | 2576 | 0.290 |
Why?
|
Preoperative Care | 1 | 2016 | 2258 | 0.290 |
Why?
|
Cell Movement | 1 | 2019 | 5216 | 0.290 |
Why?
|
Survival Analysis | 2 | 2017 | 10115 | 0.290 |
Why?
|
Leptin | 1 | 2015 | 1597 | 0.280 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2014 | 1093 | 0.270 |
Why?
|
Mice, Transgenic | 7 | 2020 | 9565 | 0.270 |
Why?
|
Fibrosis | 4 | 2023 | 2080 | 0.270 |
Why?
|
Hernia, Ventral | 3 | 2014 | 220 | 0.260 |
Why?
|
Obesity, Morbid | 1 | 2017 | 1300 | 0.260 |
Why?
|
Models, Genetic | 1 | 2016 | 3449 | 0.260 |
Why?
|
Stem Cells | 2 | 2016 | 3539 | 0.260 |
Why?
|
Muscle, Skeletal | 6 | 2023 | 4978 | 0.260 |
Why?
|
Muscular Diseases | 2 | 2023 | 553 | 0.250 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2023 | 3518 | 0.240 |
Why?
|
Cell Differentiation | 9 | 2024 | 11684 | 0.240 |
Why?
|
Patient Selection | 1 | 2017 | 4265 | 0.240 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2339 | 0.240 |
Why?
|
SEER Program | 3 | 2015 | 1473 | 0.240 |
Why?
|
Patient Compliance | 1 | 2015 | 2701 | 0.230 |
Why?
|
Bone Regeneration | 2 | 2019 | 446 | 0.220 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 85 | 0.220 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7861 | 0.220 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2024 | 72 | 0.220 |
Why?
|
Hindlimb | 2 | 2016 | 516 | 0.220 |
Why?
|
Health Care Costs | 1 | 2016 | 3270 | 0.210 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2024 | 174 | 0.210 |
Why?
|
Multipotent Stem Cells | 1 | 2024 | 201 | 0.200 |
Why?
|
Regeneration | 4 | 2023 | 1524 | 0.200 |
Why?
|
Microsurgery | 3 | 2020 | 803 | 0.200 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 61 | 0.200 |
Why?
|
Graft Rejection | 2 | 2015 | 4492 | 0.200 |
Why?
|
Humans | 50 | 2024 | 768970 | 0.200 |
Why?
|
Sternum | 2 | 2014 | 177 | 0.190 |
Why?
|
PPAR gamma | 1 | 2023 | 487 | 0.180 |
Why?
|
Upper Extremity | 2 | 2023 | 683 | 0.180 |
Why?
|
Arm | 1 | 2023 | 590 | 0.170 |
Why?
|
Cells, Cultured | 6 | 2024 | 19023 | 0.170 |
Why?
|
Female | 29 | 2023 | 397515 | 0.160 |
Why?
|
Sirolimus | 2 | 2016 | 1540 | 0.160 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2015 | 1793 | 0.160 |
Why?
|
Virilism | 1 | 2018 | 28 | 0.160 |
Why?
|
Quality of Life | 2 | 2022 | 13510 | 0.160 |
Why?
|
Registries | 1 | 2015 | 8384 | 0.150 |
Why?
|
Th2 Cells | 1 | 2024 | 1079 | 0.150 |
Why?
|
Surgical Flaps | 4 | 2020 | 1682 | 0.150 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2019 | 252 | 0.140 |
Why?
|
Genitalia, Female | 1 | 2018 | 146 | 0.140 |
Why?
|
Adipose Tissue | 4 | 2022 | 3335 | 0.140 |
Why?
|
Surgery, Plastic | 1 | 2024 | 651 | 0.140 |
Why?
|
Arthroplasty | 2 | 2016 | 310 | 0.140 |
Why?
|
Bone Morphogenetic Protein Receptors, Type I | 1 | 2017 | 97 | 0.140 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2023 | 1943 | 0.140 |
Why?
|
Frostbite | 1 | 2017 | 24 | 0.140 |
Why?
|
Smad5 Protein | 1 | 2016 | 26 | 0.140 |
Why?
|
Aggrecans | 1 | 2016 | 89 | 0.140 |
Why?
|
Mustard Compounds | 1 | 2015 | 4 | 0.130 |
Why?
|
Smad1 Protein | 1 | 2016 | 81 | 0.130 |
Why?
|
Reoperation | 3 | 2017 | 4342 | 0.130 |
Why?
|
Adult | 16 | 2017 | 223851 | 0.130 |
Why?
|
Apatites | 1 | 2015 | 19 | 0.130 |
Why?
|
Phenylpropionates | 1 | 2015 | 34 | 0.130 |
Why?
|
Receptor, TIE-2 | 1 | 2016 | 183 | 0.130 |
Why?
|
Michigan | 1 | 2016 | 336 | 0.130 |
Why?
|
Nerve Compression Syndromes | 1 | 2017 | 160 | 0.130 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2016 | 160 | 0.130 |
Why?
|
Osteocalcin | 1 | 2016 | 277 | 0.130 |
Why?
|
Mediastinitis | 1 | 2015 | 49 | 0.130 |
Why?
|
Receptors, Retinoic Acid | 1 | 2016 | 229 | 0.130 |
Why?
|
Male | 25 | 2023 | 365203 | 0.120 |
Why?
|
Postoperative Complications | 5 | 2024 | 15889 | 0.120 |
Why?
|
Aromatase Inhibitors | 1 | 2019 | 519 | 0.120 |
Why?
|
Sex Reassignment Surgery | 1 | 2018 | 165 | 0.120 |
Why?
|
Hair Follicle | 1 | 2017 | 219 | 0.120 |
Why?
|
Hip | 1 | 2016 | 256 | 0.120 |
Why?
|
Joints | 1 | 2016 | 324 | 0.120 |
Why?
|
Hypersensitivity | 1 | 2024 | 1173 | 0.120 |
Why?
|
Mice, Obese | 1 | 2015 | 418 | 0.120 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2014 | 56 | 0.120 |
Why?
|
Contracture | 1 | 2017 | 236 | 0.120 |
Why?
|
Internal Fixators | 1 | 2015 | 184 | 0.120 |
Why?
|
Sternotomy | 1 | 2015 | 132 | 0.120 |
Why?
|
Tissue Transplantation | 1 | 2015 | 128 | 0.110 |
Why?
|
Gene Knockout Techniques | 1 | 2017 | 808 | 0.110 |
Why?
|
Luminescent Measurements | 1 | 2015 | 342 | 0.110 |
Why?
|
Adaptive Immunity | 2 | 2016 | 733 | 0.110 |
Why?
|
Rectus Abdominis | 1 | 2014 | 102 | 0.110 |
Why?
|
Middle Aged | 16 | 2017 | 223737 | 0.110 |
Why?
|
Protein Kinase Inhibitors | 3 | 2019 | 5707 | 0.110 |
Why?
|
Luminescent Proteins | 1 | 2016 | 839 | 0.110 |
Why?
|
Body Surface Area | 1 | 2014 | 206 | 0.110 |
Why?
|
Calciphylaxis | 1 | 2015 | 129 | 0.110 |
Why?
|
Pericytes | 1 | 2016 | 299 | 0.110 |
Why?
|
Elbow Joint | 1 | 2017 | 359 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6547 | 0.110 |
Why?
|
Aged | 12 | 2017 | 171786 | 0.100 |
Why?
|
Abdominal Wall | 1 | 2014 | 166 | 0.100 |
Why?
|
NFATC Transcription Factors | 1 | 2015 | 393 | 0.100 |
Why?
|
Bone Density | 2 | 2016 | 3574 | 0.100 |
Why?
|
Muscular Atrophy | 1 | 2015 | 335 | 0.100 |
Why?
|
Cell Proliferation | 3 | 2019 | 10486 | 0.100 |
Why?
|
Blast Injuries | 1 | 2016 | 324 | 0.100 |
Why?
|
Mice, Knockout | 3 | 2017 | 14484 | 0.100 |
Why?
|
Debridement | 2 | 2017 | 494 | 0.100 |
Why?
|
Life Expectancy | 1 | 2019 | 1249 | 0.100 |
Why?
|
Bone Diseases, Metabolic | 1 | 2016 | 411 | 0.100 |
Why?
|
Median Nerve | 1 | 2012 | 133 | 0.100 |
Why?
|
Abdominal Fat | 1 | 2014 | 221 | 0.100 |
Why?
|
Recurrence | 2 | 2016 | 8513 | 0.100 |
Why?
|
Retrospective Studies | 11 | 2017 | 81903 | 0.100 |
Why?
|
Tendon Injuries | 1 | 2015 | 329 | 0.100 |
Why?
|
Apyrase | 1 | 2014 | 376 | 0.100 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1705 | 0.100 |
Why?
|
Cadherins | 1 | 2016 | 906 | 0.100 |
Why?
|
Rats | 2 | 2019 | 23786 | 0.090 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2017 | 716 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2015 | 12253 | 0.090 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2019 | 1535 | 0.090 |
Why?
|
Young Adult | 6 | 2017 | 60131 | 0.090 |
Why?
|
Stromal Cells | 1 | 2016 | 1337 | 0.090 |
Why?
|
Animals, Newborn | 1 | 2016 | 2683 | 0.090 |
Why?
|
Inflammation | 3 | 2019 | 10868 | 0.090 |
Why?
|
Radiotherapy | 1 | 2017 | 1506 | 0.090 |
Why?
|
Range of Motion, Articular | 1 | 2017 | 1599 | 0.090 |
Why?
|
Monocytes | 1 | 2020 | 2603 | 0.090 |
Why?
|
Ligands | 1 | 2017 | 3283 | 0.090 |
Why?
|
Extracellular Matrix Proteins | 1 | 2014 | 835 | 0.090 |
Why?
|
Methylene Blue | 1 | 2010 | 156 | 0.090 |
Why?
|
Gene Regulatory Networks | 2 | 2015 | 1752 | 0.090 |
Why?
|
Skin | 3 | 2019 | 4506 | 0.080 |
Why?
|
Follow-Up Studies | 3 | 2016 | 39394 | 0.080 |
Why?
|
Prognosis | 3 | 2015 | 30046 | 0.080 |
Why?
|
Choice Behavior | 1 | 2015 | 848 | 0.080 |
Why?
|
Piperazines | 1 | 2019 | 2553 | 0.080 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4926 | 0.080 |
Why?
|
Mastectomy, Segmental | 1 | 2014 | 960 | 0.080 |
Why?
|
Obesity | 3 | 2024 | 13091 | 0.080 |
Why?
|
Cytokines | 3 | 2024 | 7453 | 0.080 |
Why?
|
Models, Animal | 1 | 2015 | 2122 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 2 | 2016 | 8144 | 0.080 |
Why?
|
Chimera | 1 | 2009 | 454 | 0.080 |
Why?
|
Adenosine Triphosphate | 1 | 2014 | 2003 | 0.070 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2010 | 156 | 0.070 |
Why?
|
Coloring Agents | 1 | 2010 | 564 | 0.070 |
Why?
|
Tumor Burden | 1 | 2014 | 1913 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2017 | 1811 | 0.070 |
Why?
|
Decompression, Surgical | 1 | 2012 | 610 | 0.070 |
Why?
|
Lymph Nodes | 2 | 2020 | 3473 | 0.070 |
Why?
|
Pyridines | 1 | 2019 | 2895 | 0.070 |
Why?
|
Phantoms, Imaging | 1 | 2016 | 2533 | 0.070 |
Why?
|
Fractures, Bone | 1 | 2019 | 2063 | 0.070 |
Why?
|
Up-Regulation | 1 | 2015 | 4148 | 0.070 |
Why?
|
Acute Disease | 1 | 2017 | 7245 | 0.070 |
Why?
|
Fibroblasts | 1 | 2016 | 4179 | 0.070 |
Why?
|
Macrophages | 2 | 2020 | 5801 | 0.060 |
Why?
|
Propensity Score | 1 | 2014 | 1968 | 0.060 |
Why?
|
Lymphatic Metastasis | 1 | 2014 | 2916 | 0.060 |
Why?
|
Time Factors | 3 | 2017 | 40261 | 0.060 |
Why?
|
Suture Techniques | 1 | 2010 | 779 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 36854 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2015 | 14752 | 0.060 |
Why?
|
Surgical Wound Infection | 1 | 2014 | 1547 | 0.060 |
Why?
|
Body Composition | 1 | 2014 | 2462 | 0.060 |
Why?
|
Adolescent | 4 | 2017 | 89244 | 0.060 |
Why?
|
Drainage | 1 | 2010 | 1184 | 0.060 |
Why?
|
RNA | 1 | 2014 | 2727 | 0.060 |
Why?
|
Gene Expression | 1 | 2016 | 7603 | 0.050 |
Why?
|
Fascia | 2 | 2014 | 143 | 0.050 |
Why?
|
Survival Rate | 2 | 2015 | 12873 | 0.050 |
Why?
|
Intercostal Nerves | 1 | 2022 | 28 | 0.050 |
Why?
|
Porosity | 1 | 2023 | 352 | 0.050 |
Why?
|
Calcium | 1 | 2015 | 5792 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8559 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 5 | 2016 | 20776 | 0.050 |
Why?
|
Preoperative Period | 2 | 2014 | 565 | 0.050 |
Why?
|
Patient Discharge | 1 | 2015 | 3491 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2023 | 751 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2015 | 59739 | 0.050 |
Why?
|
Lymphatic System | 1 | 2022 | 251 | 0.050 |
Why?
|
Risk Factors | 4 | 2023 | 74976 | 0.050 |
Why?
|
Aging | 2 | 2023 | 8745 | 0.050 |
Why?
|
Denervation | 1 | 2022 | 265 | 0.050 |
Why?
|
Random Allocation | 2 | 2015 | 2394 | 0.050 |
Why?
|
Subcutaneous Fat | 2 | 2014 | 404 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2015 | 12806 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12095 | 0.040 |
Why?
|
Biopsy, Needle | 2 | 2015 | 1626 | 0.040 |
Why?
|
Head and Neck Neoplasms | 1 | 2014 | 2931 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2017 | 26428 | 0.040 |
Why?
|
Adipogenesis | 1 | 2022 | 371 | 0.040 |
Why?
|
Gene Expression Regulation | 4 | 2020 | 11932 | 0.040 |
Why?
|
Hemodynamics | 1 | 2010 | 4199 | 0.040 |
Why?
|
Models, Biological | 1 | 2015 | 9499 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11262 | 0.040 |
Why?
|
Physical Therapy Modalities | 1 | 2023 | 533 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12562 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 9080 | 0.040 |
Why?
|
DNA Nucleotidyltransferases | 1 | 2019 | 177 | 0.040 |
Why?
|
Founder Effect | 1 | 2019 | 185 | 0.040 |
Why?
|
Phenotype | 1 | 2016 | 16731 | 0.040 |
Why?
|
Education, Medical | 1 | 2010 | 1742 | 0.040 |
Why?
|
Infant | 2 | 2017 | 36556 | 0.040 |
Why?
|
Child, Preschool | 2 | 2017 | 42683 | 0.040 |
Why?
|
Rewarming | 1 | 2017 | 64 | 0.030 |
Why?
|
Transcription Factors | 1 | 2016 | 12174 | 0.030 |
Why?
|
Algorithms | 1 | 2017 | 14201 | 0.030 |
Why?
|
United States | 2 | 2015 | 73186 | 0.030 |
Why?
|
Tissue Scaffolds | 1 | 2023 | 951 | 0.030 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2020 | 642 | 0.030 |
Why?
|
Body Weights and Measures | 1 | 2016 | 208 | 0.030 |
Why?
|
Stilbenes | 1 | 2016 | 155 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 18068 | 0.030 |
Why?
|
Sampling Studies | 1 | 2017 | 615 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2017 | 65480 | 0.030 |
Why?
|
Smad Proteins, Receptor-Regulated | 1 | 2014 | 8 | 0.030 |
Why?
|
Foot Injuries | 1 | 2017 | 154 | 0.030 |
Why?
|
Transplantation, Isogeneic | 1 | 2015 | 249 | 0.030 |
Why?
|
Cardiac Surgical Procedures | 1 | 2010 | 3683 | 0.030 |
Why?
|
Skull | 1 | 2019 | 830 | 0.030 |
Why?
|
Child | 3 | 2017 | 80960 | 0.030 |
Why?
|
Phagocytosis | 1 | 2020 | 1530 | 0.030 |
Why?
|
Hand Injuries | 1 | 2017 | 240 | 0.030 |
Why?
|
Blood Cells | 1 | 2016 | 309 | 0.030 |
Why?
|
Risk Assessment | 4 | 2017 | 24333 | 0.030 |
Why?
|
Chimerism | 1 | 2014 | 156 | 0.030 |
Why?
|
Hydrolysis | 1 | 2014 | 646 | 0.030 |
Why?
|
Morphogenesis | 1 | 2017 | 747 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2017 | 1049 | 0.030 |
Why?
|
Multiple Trauma | 1 | 2015 | 369 | 0.030 |
Why?
|
Tissue Engineering | 1 | 2023 | 1893 | 0.030 |
Why?
|
Motivation | 1 | 2022 | 2025 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2015 | 1769 | 0.030 |
Why?
|
Gender Identity | 1 | 2018 | 770 | 0.030 |
Why?
|
Lower Extremity | 1 | 2020 | 1217 | 0.020 |
Why?
|
Bone Development | 1 | 2015 | 473 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2015 | 11116 | 0.020 |
Why?
|
Pain Measurement | 1 | 2022 | 3586 | 0.020 |
Why?
|
Pain, Postoperative | 1 | 2022 | 1767 | 0.020 |
Why?
|
Surgical Mesh | 1 | 2014 | 316 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2015 | 1081 | 0.020 |
Why?
|
Counseling | 1 | 2018 | 1554 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3116 | 0.020 |
Why?
|
Mutation | 1 | 2015 | 30266 | 0.020 |
Why?
|
Logistic Models | 2 | 2014 | 13318 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2015 | 936 | 0.020 |
Why?
|
Intra-Abdominal Fat | 1 | 2014 | 625 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2014 | 1252 | 0.020 |
Why?
|
Administration, Topical | 1 | 2010 | 704 | 0.020 |
Why?
|
Reference Values | 1 | 2015 | 4940 | 0.020 |
Why?
|
Iliac Artery | 1 | 2009 | 344 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15471 | 0.020 |
Why?
|
Radial Artery | 1 | 2009 | 188 | 0.020 |
Why?
|
Bone Density Conservation Agents | 1 | 2015 | 797 | 0.020 |
Why?
|
Peptides | 1 | 2020 | 4353 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5033 | 0.020 |
Why?
|
Spine | 1 | 2014 | 1141 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2015 | 6236 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3629 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5906 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 6086 | 0.020 |
Why?
|
Pyrazoles | 1 | 2016 | 2029 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 2276 | 0.020 |
Why?
|
Femoral Artery | 1 | 2009 | 829 | 0.020 |
Why?
|
Graft Survival | 1 | 2014 | 3888 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8317 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9621 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4076 | 0.010 |
Why?
|
Pain | 1 | 2017 | 5100 | 0.010 |
Why?
|
Sex Factors | 1 | 2015 | 10633 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2017 | 3838 | 0.010 |
Why?
|
Comorbidity | 1 | 2014 | 10592 | 0.010 |
Why?
|
Research Design | 1 | 2015 | 6214 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2015 | 14794 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20245 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2014 | 22296 | 0.010 |
Why?
|
Incidence | 1 | 2014 | 21547 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 54962 | 0.010 |
Why?
|